NCT06958263

Brief Summary

Chronic non-specific low back pain is a common health problem that significantly affects the quality of life of individuals. Increased pain intensity leads to deficiencies in the body's sensory organization, resulting in decreased awareness. This can lead to dysfunction in body awareness, which is known as the ability of individuals to perceive the sensations and conditions of their bodies. Body awareness plays a critical role in pain management and mobility. Chronic pain causes constant stimulation in the nervous system, causing central sensitization, which is when the central nervous system becomes overly sensitive to pain signals. As a result, a decrease in the pain threshold, constant pain, and increased muscle tension occur. Increased pain intensity and decreased awareness can result in a decrease in the maintenance of optimal functions, affecting muscular endurance. Inadequate muscular endurance can increase low back pain and make it difficult for individuals to perform their daily activities. Therefore, this study aims to examine the relationship between body awareness, central sensitization, disability, and muscular endurance in patients with chronic non-specific low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 6, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

May 8, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

April 25, 2025

Last Update Submit

May 12, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • Central sensitization

    Central sensitization will be assessed with the "Central Sensitization Scale". The total score range is between 0-100 points. As the score increases, sensitization increases and 40 points and above are considered higher sensitization.

    Baseline

  • Pain severity

    Pain intensity will be assessed with Vizüel Analog Scale (VAS). VAS varies between 0-10 and the higher the score, the greater the pain.

    Baseline

  • Pain pressure threshold

    Pressure pain threshold will be measured with an algometer in kg. High values indicate a high pain threshold.

    Baseline

  • Disability levels

    Disability will be measured by the Oswestry Disability Index. The total score ranges from 0-100 and the higher the score, the higher the level of disability.

    Baseline

  • Body awereness

    It will be measured with a body awareness survey. The total score varies between 18-126 and as the score increases, awareness increases

    Baseline

  • Low back awereness

    It will be measured with the Fremantle Waist Awareness Questionnaire (FBFA). The total score varies between 0-36 and the awareness decreases as the score increases

    Baseline

  • Trunk muscle endurance

    The Stabilizer Pressure Biofeedback Unit will be used to evaluate the multifidus muscle endurance. The time maintained at 40 mmHg pressure will be recorded. As the time increases, the endurance increases.

    Baseline

Study Arms (2)

Higher sensitization

Patients with chronic non-specific low back pain with high sensitization will be included.

Normal sensitization

Patients with chronic non-specific low back pain with normal sensitization will be included.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic non-specific low back pain will be included in this study.

You may qualify if:

  • Being between the ages of 18-65
  • Being diagnosed with chronic non-specific low back pain (Pain between the gluteal folds and the 12th ribs that lasts at least 12 weeks and has no known pathoanatomical cause)
  • Being willing to participate in the study

You may not qualify if:

  • Having a psychological disorder, mental disorder, cancer and severe depression
  • Having a history of primary or metastatic spinal malignancy, spinal fracture
  • Having a neurological disease (Hemiplegia, Multiple Sclerosis, Parkinson's, etc.)
  • Being diagnosed with advanced osteoporosis
  • Having a history of surgery or acute infection in the lumbar region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karabuk University, Physiotherapy and Rehabilitation Application and Research Center

Karabük, Turkey (Türkiye)

Location

Related Publications (2)

  • Nijs J, Van Houdenhove B, Oostendorp RA. Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. Man Ther. 2010 Apr;15(2):135-41. doi: 10.1016/j.math.2009.12.001. Epub 2009 Dec 24.

    PMID: 20036180BACKGROUND
  • Colgan DD, Eddy A, Green K, Oken B. Adaptive body awareness predicts fewer central sensitization-related symptoms and explains relationship between central sensitization-related symptoms and pain intensity: A cross-sectional study among individuals with chronic pain. Pain Pract. 2022 Feb;22(2):222-232. doi: 10.1111/papr.13083. Epub 2021 Nov 11.

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Musa Güneş, PhD

    Karabuk University

    STUDY DIRECTOR
  • Seher İmanur

    Karabuk University

    PRINCIPAL INVESTIGATOR
  • Elif Aydoğan

    Karabuk University

    PRINCIPAL INVESTIGATOR
  • Bedirhan Turan

    Karabuk University

    PRINCIPAL INVESTIGATOR
  • Aydın Sinan Apaydın, PhD

    Karabuk University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, PhD

Study Record Dates

First Submitted

April 25, 2025

First Posted

May 6, 2025

Study Start

May 8, 2025

Primary Completion

December 30, 2025

Study Completion

February 1, 2026

Last Updated

May 14, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations